Patents by Inventor Lucilla Poston

Lucilla Poston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8283451
    Abstract: The present invention relates to a method of predicting pre-eclampsia (PE). The present invention also relates to a diagnostic kit for performing a method of predicting PE. In particular, the method determining the level of two or more markers selected from placenta growth factor (PlGF), plasminogen activator inhibitor-1 (PAI-1), plasminogen activator inhibitor-2 (PAI-2) and leptin.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: October 9, 2012
    Assignee: Perkinelmer Las, Inc.
    Inventors: Lucilla Poston, Paul Townsend Seed, Beverley Jane Hunt, Lucy Charlotte Chappell
  • Publication number: 20120157422
    Abstract: The invention provides a method for identifying whether a pregnant subject has an increased risk of preterm labour comprising measuring the progesterone concentration in a sample obtained from the subject, wherein a reduced progesterone concentration is indicative of an increased risk of preterm labour and delivery.
    Type: Application
    Filed: April 6, 2010
    Publication date: June 21, 2012
    Applicants: UCL BUSINESS PLC, KING'S COLLEGE LONDON
    Inventors: Lucilla Poston, Paul Seed, Gillian Lachelin
  • Publication number: 20110300564
    Abstract: The present invention relates to a method of predicting pre-eclampsia (PE). The present invention also relates to a diagnostic kit for performing a method of predicting PE. In particular, the method determining the level of two or more markers selected from placenta growth factor (PlGF), plasminogen activator inhibitor-1 (PAI-1), plasminogen activator inhibitor-2 (PAI-2) and leptin.
    Type: Application
    Filed: August 19, 2011
    Publication date: December 8, 2011
    Applicant: PERKINELMER LAS, INC.
    Inventors: Lucilla POSTON, Paul Townsend SEED, Beverley Jane HUNT, Lucy Charlotte Chappell
  • Patent number: 8017734
    Abstract: The present invention relates to a method of predicting pre-eclampsia (PE). The present invention also relates to a diagnostic kit for performing a method of predicting PE. In particular, the method determining the level of two or more markers selected from placenta growth factor (PlGF), plasminogen activator inhibitor-1 (PAI-1), plasminogen activator inhibitor-2 (PAI-2) and leptin.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: September 13, 2011
    Assignee: PerkinElmer LAS, Inc.
    Inventors: Lucilla Poston, Paul Townsend Seed, Beverley Jane Hunt, Lucy Charlotte Chappell
  • Patent number: 7638287
    Abstract: The technology described herein relates to methods of detecting or predicting pre-eclampsia (PE). The technology described herein also relates to commercial packages, such as diagnostic kits, for performing a method of detecting or predicting PE. In particular, the technology described herein provides methods of predicting pre-eclampsia when determining the levels of biochemical markers.
    Type: Grant
    Filed: January 16, 2007
    Date of Patent: December 29, 2009
    Assignee: PerkinElmer LAS, Inc.
    Inventors: Lucilla Poston, Andrew Shennan
  • Publication number: 20090011429
    Abstract: The present invention relates to a method of predicting pre-eclampsia (PE). The present invention also relates to a diagnostic kit for performing a method of predicting PE. In particular, the method determining the level of two or more markers selected from placenta growth factor (P1GF), plasminogen activator inhibitor-1 (PAI-1), plasminogen activator inhibitor-2 (PAI-2) and leptin.
    Type: Application
    Filed: September 15, 2008
    Publication date: January 8, 2009
    Applicant: PerkinElmer LAS, Inc.
    Inventors: Lucilla Poston, Paul Townsend Seed, Beverley Jane Hunt, Lucy Charlotte Chappell
  • Patent number: 7425419
    Abstract: The present invention relates to a method of predicting pre-eclampsia (PE). The present invention also relates to a diagnostic kit for performing a method of predicting PE. In particular, the method determining the level of two or more markers selected from placenta growth factor (PIGF), plasminogen activator inhibitor-1 (PAI-1) plasminogen activator inhibitor-2 (PAI-2) and leptin.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: September 16, 2008
    Assignee: King's College London
    Inventors: Lucilla Poston, Paul Townsend Seed, Beverley Jane Hunt, Lucy Charlotte Chappell
  • Publication number: 20070178530
    Abstract: The technology described herein relates to methods of detecting or predicting pre-eclampsia (PE). The technology described herein also relates to commercial packages, such as diagnostic kits, for performing a method of detecting or predicting PE. In particular, the technology described herein provides methods of predicting pre-eclampsia when determining the levels of biochemical markers.
    Type: Application
    Filed: January 16, 2007
    Publication date: August 2, 2007
    Applicant: PerkinElmer LAS, Inc.
    Inventors: Lucilla Poston, Andrew Shennan
  • Publication number: 20040038305
    Abstract: The present invention relates to a method of predicting pre-eclampsia (PE). The present invention also relates to a diagnostic kit for performing a method of predicting PE. In particular, the method determining the level of two or more markers selected from placenta growth factor (PIGF), plasminogen activator inhibitor-1 (PAI-1) plasminogen activator inhibitor-2 (PAI-2) and leptin.
    Type: Application
    Filed: September 4, 2003
    Publication date: February 26, 2004
    Inventors: Lucilla Poston, Paul Townsend Seed, Beverley Jane Hunt, Luey Charlotte Chappell